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IMPLICATIONS ANDObjective: We conducted a descriptive study of the correlates of refusal and acceptance of human
papillomavirus (HPV) vaccination by rural parents of preadolescent and adolescent children. We
hypothesized that the correlates of parents who allow their children aged 9 to 13 years to get the
HPV vaccine and those of parents who do not allow vaccination would differ signiﬁcantly.
Methods: This cross-sectional study was implemented during the school years 2009e2011 in the
elementary and middle schools of three rural counties in Georgia. Parents were recruited at school
functions to complete an anonymous validated survey.
Results: Parents who chose to vaccinate their children or intended to vaccinate were twice as likely
to be from a race other than African American and 2.7 times more likely to have a religion other
than Baptist. Using stepwise logistic regression and after adjustment for race and religion, we
found that parents who had vaccinated or intended to vaccinate had signiﬁcantly higher scores on
perceived barriers (1.02 times more likely to vaccinate) and lower scores on perceived beneﬁts
(1.01 times more likely to vaccinate) (model p < .001).
Conclusions: The results suggest that healthcare providers in rural areas can increase HPV vaccine
uptake and reduce HPV-related cancers by using a multifaceted approach to educating their
patients within the context of the patients’ cultural values, geographic location, and economic
situation. Such an approach could dispel misinformation and increase vaccine uptake.
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The ﬁndings imply that
a multifaceted approach




culture) must be recog-
nized when educating par-
ents about HPV vaccination.
In addition, emphasizing
the beneﬁts of HPV vacci-
nation as a cancer preven-
tive can increase HPV
vaccine uptake in rural
areas.Human papillomavirus (HPV) infection is etiologically linked
to cancers of the cervix, anus, oropharynx, penis, vagina, and
vulva [1]. Current incidence data indicate that HPV infection maybe associated with 96%e99% of cervical cancers [1e3], 90%e93%
of anal cancers [1,4], 12%e63% of oropharyngeal cancers [1,5],
36%e40% of penile cancers [1,6], 40% of vaginal cancers [1,7],
40%e51% of vulvar cancers [1,8], and 500,000 cases of cervical
cancer worldwide [1]. Cancers related to HPV infection impose
an enormous health burden of more than $3.7 billion annually in
the United States [9]. As incidence rates of HPV-related cancers of
the anus, oropharyngeal cavity, and vulva continue to increase,
preventing these types of cancers is crucial, especially for
adolescents living in rural areas who may have limited or no
access to primary healthcare or prevention services [10].
Table 1
Enrollment and parental surveys completed: Study of human papillomavirus
vaccine uptake in three rural Georgia counties, 2009e2011
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tial element of health promotion in pediatric and adolescent
healthcare for boys and girls [11]. The Centers for Disease Control
and Prevention and the Advisory Committee on Immunization
Practices recommend vaccinating girls and boys as early as
9 years of age with the recommended age range being 9 to
26 years [12]. In the isolated communities where our research
was conducted, preadolescents and adolescents cannot be
vaccinated without parental consent. An opportunity to reduce
HPV-related cancer was clear after the principal investigator (PI)
reviewed vaccine rates in rural Georgia counties and found that
the HPV vaccine rate was less than 18% [13].
Georgia has the highest estimated rate of new cancer cases,
including cervical cancer, in the southeastern United States [14].
Despite prevention measures, cervical cancer rates are rising
[15]. After the United States Food and Drug Administration (FDA)
approved the HPV vaccine in 2006, several studies of parental
acceptance of the HPV vaccine noted that acceptance was asso-
ciated with two factors: (1) parents’ knowledge of, attitude
toward, and trust in healthcare providers; and (2) parents’ belief
in a causal relationship between HPV infection and cervical
cancer [16,17]. But these studies focused on parents with
daughters only. Nonetheless, the results imply that parents’
resistance to vaccinating daughters against HPV is attributable in
large part to concerns that it will lead to or encourage early
sexual activity, promiscuity, or irresponsibility [18,19]. This initial
suggestion has been refuted by current research showing no link
between getting the HPV vaccine and behavioral disinhibition
[19e22]. The research ﬁndings by the Advisory Committee on
Immunization Practices support the premise that limited infor-
mation about sexual and reproductive health in rural commu-
nities can foster mistrust among parents and, as a consequence,
may contribute to healthcare disparities [16,23e25]. Although
populations in rural areas may be more static and stable, they are
not immune to HPV infection.
Recent evidence suggests that HPV vaccine series initiation
among boys may be as low as 2% nationally, and this rate is likely
to be much lower in rural areas, as the series initiation rate
among females in rural Georgia is barely half the national
average [26,27]. The limited time since the approval of the HPV
vaccine for boys has precluded accurate measurement of series
initiation rates among males in rural Georgia. Further, at the
initiation of our study, no research had investigated HPV vaccine
acceptance by parents/caregivers of boys in rural areas. There-
fore, in November 2010, after the FDA approved the HPV vaccine
for boys, we began collecting data on parents/caregivers with
sons and subsequently their willingness to vaccinate their sons
and daughters with the HPV vaccine.
We focused our research on parents with both girls and boys
living in the rural isolated counties of Burke, Lincoln, and
Screven counties in Georgia, where the rates of HPV-related
cancers (e.g., cervical cancer and cancers of the head, neck,
and throat) are higher than those in urban areas, and the
conﬂuence of social determinants of health is discrete from
urban areas [14]. This decision was made because most research
on parents’ acceptance of the HPV vaccine was completed
before the vaccine was licensed, and it focused predominantly
on women living in accessible urban areas because the original
focus was on preventing cervical cancer [23,28e30]. Thus, our
research focuses on parents in rural communities whose chil-
dren are at disproportionately high risk for HPV-related disease
and inadequate healthcare. Because earlier studies on parents’acceptance of the HPV vaccine did not include rural residents,
our study ﬁlls a large gap in scientiﬁc knowledge. We hypoth-
esized that we would ﬁnd marked differences by race or
ethnicity among these rural parents who chose to vaccinate or
intended to vaccinate their boys and girls aged 9 to 13 years.
Using the theoretical concepts in the Health Belief Model, we
hypothesized that there would also be differences in the
perceived severity of HPV infection, perceived vulnerability to
HPV infection, perceived beneﬁts of HPV vaccination, and
perceived barriers to HPV vaccination [31].
Methods
We used a descriptive cross-sectional design, surveys, and
quantitative analysis. The participants were parents or caregivers
of children aged 9 to 13 years old residing in rural areas and
attending elementary or middle school during the 2009e2011
school years. The study’s sample size was based on the number
of childrenenrolled in the elementaryandmiddle schools in three
rural isolated counties (Burke, Lincoln, and Screven counties in
Georgia) that have a lowmedian income and with an enrollment
of at least 50% African Americans. Table 1 shows the student
enrollment in these schools (not the exact number of parentswho
wouldqualify toparticipate) and thenumbersof surveys collected
from parents who qualiﬁed to be included in the survey. To be
included in the survey, respondents had to be a parent or primary
caregiver (such as a foster parent or relative) responsible for girls
or boys aged9 to13years. Theyalsohad to reside in the counties of
interest, speak and read English, and be at least 18 years of age.
Study procedures
Our studywas conducted from September 2009 through April
2011. Because school superintendents understood the impor-
tance of this study and the requirements of the Family Educa-
tional Rights and Privacy Act, school superintendents kept all
parent and student information anonymous [37]. The PI metwith
each school principal to explain the study and its implementa-
tion, and hadmany face-to-facemeetings and phone conferences
with school superintendents, school principals, community
leaders (e.g., church pastors), parents, and school nurses. All
were given detailed information about the study, and they gave
written letters of support to the PI [32,33].
After meeting with school superintendents, principals, and
school nurses, the PI met with each school’s clerical staff to
explain the study procedures. The PI explained the recruitment
guidelines and criteria for parents to be included in the study and
gave clerical staff an example of the information letter for
parents. This information letter included the study’s purpose,
instructions on how to participate, a description of an incentive
to participate (gift card to a local grocery store), information on
Emory University’s institutional review board, and contact
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University’s institutional review board were posted at the
participating schools before data collection.
Events at which data were collected differed from school to
school and from county to county; they included Parent-Teacher
Association meetings, athletic events, parent-teacher conference
days, holiday functions, and concerts. If parents decided to
participate, they were directed to a private area and handed
a copy of the information letter for parents so they could review
information and make the decision to complete the survey or
decline to take it. A trained research assistant using computer-
assisted personal interviewing survey software on a laptop
computer asked parents the questions and entered their answers
into the computer-assisted personal interviewing software
program [34].
Measures
The theoretical framework guiding this study was selected
because it was developed to study behaviors related to vaccina-
tion. The Health Belief Model (HBM) identiﬁes determinants of
health-related behavior for a speciﬁc health behavior, like
vaccinating a child. In addition, the HBM postulates four factors
that account for health-related behavior: perceived vulnerability
to a threat (like HPV infection), perceived severity of HPV
infection or consequences of not being vaccinated, perceived
beneﬁts of being vaccinated, and perceived barriers to being
vaccinated (Figure 1) [31]. Using the HBM, we developed survey
items to assess relevant constructs in the model. The survey, the
Parental HPV Survey, was validated by using 28 Likert scale
coded responses (1 ¼ disagree to 5 ¼ agree) for the parents of
200 girls. The results of the Parental HPV Survey validation and
reliability analyses, which are being published elsewhere [35],Figure 1. Health belief model with parental human papillomavirus (HPV) survey ite
vaccine uptake in three rural Georgia counties, 2009e2011.yielded an overall Cronbach’s alpha of .957: .80 for perceived
vulnerability, .89 for perceived severity, .85 for perceived bene-
ﬁts, and .92 for perceived barriers (Table 2).
After the survey items were validated, we collapsed the 200
responses into dichotomous responses of 0 ¼ no/disagree and
1 ¼ yes/agree so they could be merged with the data collected
later. For the rest of the surveys, we offered only one of two
possible responses (yes or no; agree or disagree). This decision to
dichotomize the responses was based on the pattern distribu-
tions observed in responses of parents of the initial 200 girls. In
addition, two items were added to the later version of the survey,
and two somewhat redundant items related to cost and expense
were merged. This merged dataset of 519 (200 from the valida-
tion survey and 319 later) has 25 items instead of the original 28.
Table 2 lists the ﬁnal items for each of the four constructs and
compares Cronbach’s alphas (which are also the Kuder-
Richardson-20 measures of internal consistency for dichoto-
mously scored items) between the original Likert scale dataset
for 200 girls and the updated merged dichotomously scored
dataset for the ﬁnal 519 [36,37]. So, theoretically, the higher the
score on the subscale (perceived vulnerability to HPV infection,
perceived severity of HPV infection, perceived barriers to HPV
vaccination, and perceived beneﬁts to HPV vaccination), the
more likely the parent had vaccinated the child or would vacci-
nate the child.
Dependent variables
Vaccine uptake was measured by one survey item with
a dichotomous response that asks whether the parent/guardian
had his or her child vaccinated (or was in the process of
completing the three-shot vaccine series) or intended to have his
or her child vaccinated (Yes) or not (No).m examples mapped to constructs that predict HPV vaccination: Study of HPV
Table 2
Items and reliability coefﬁcients of four theoretical constructs in the parental human papillomavirus (HPV) survey: Study of HPV vaccine uptake in three rural Georgia
counties, 2009e2011
Theoretical construct
 Speciﬁc items (responses coded 0 ¼ no/
disagree; 1 ¼ yes/agree)
Original scale validation









Perceived vulnerability .80 .613 .332 .667 .618
 HPV is a sexually transmitted disease
 Using condoms can prevent HPV
 Genital warts are caused by HPV
 People with HPV might not have symptoms
 HPV makes you unable to have children
Perceived severity .89 .610 .495 .637 .624
 I worry that my child might get HPV
 HPV can cause cervical cancer
 Treatment for HPV is painful
 Required vaccinations protect children from getting disease from unvaccinated children
 I understand exactly what the HPV vaccine is for
 Having genital warts makes it very difﬁcult to ﬁnd a sexual partner
Perceived beneﬁts .85 .574 .130 .647 .639
 Children should only get vaccinated for serious diseases
 I am more likely to trust vaccinations that have been around awhile
 Vaccinations are getting better all the time because of research
 Healthy children do not need vaccinations
 A vaccine against HPV could prevent future problems for my child
 Giving my child a new vaccine is like performing an experiment on them
 Most people I know think vaccinating children with the HPV vaccine before they are teenagers is a good idea
 A teenager should be able to get the HPV vaccination without a parent’s consent
Perceived barriers .92 .532 .424 .627 .549
 If this new HPV vaccine was available when my child (daughter) was an infant, they would be vaccinated against HPV infection
 Shots are very painful for my child so I would rather not vaccinate him/her
 If the new HPV vaccine is not required, I will not vaccinate my child (daughter)
 I understand that the HPV vaccine is very expensive so I will not vaccinate my childa/I think that even if the vaccine is expensive I will be able to vaccinate my
daughterb
 Generally I do what my doctor recommends so I will vaccinate my child (daughter)
 When I make a decision to vaccinate my child my mind is made upa/When I decide to get my daughter vaccinated I believe I will be able to get her vaccinated; in
other words, I feel conﬁdent I can get my daughter vaccinatedb
a Wording used in the study whose results are presented here.
b Wording used in the original validation study completed through the support of the Robert Wood Johnson Foundation.
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Summary scores were calculated for each of the four
subscales (constructs) as the percentage of agree/yes items out of
the total number of items in each subscale. For example,
a perceived vulnerability score of 40 indicates that the individual
agreed with two of the ﬁve items in this subscale. These survey
item scores were examined as potential correlates for parents’
intention to have children aged 9 to 13 vaccinated with the HPV
vaccine. These four constructs or subscale scores were summa-
rized and divided for comparison by the two response groups:
parents intending to or having had their children vaccinated
(Yes) and parents who do not intend or have not had their chil-
dren vaccinated (No).
Data analysis
Before analysis, all data were reviewed for completeness,
outliers, and violation of assumptions. Descriptive statistics were
calculated for all variables, with sample sizes and missing data
noted. Parents who intend to or have had their children vacci-
nated were compared with parents who do not intend or have
not had their children vaccinated. The demographics and
construct scores of the three counties were also compared. We
used t tests and analysis of variance F tests for all continuous
variables and c2 tests for all categorical variables. Demographic
variables with signiﬁcant t test, F test, or c2 test results relative tovaccination outcome as well as the four HBM constructs were
included in a ﬁnal logistic regression model. The ﬁnal logistic
regression model used a two-step sequential process using
likelihood ratio variable selection methods to down-select the
best set of predictive measures within each of two blocks: an
initial block for the signiﬁcant demographic variables followed
by a second block of the four HBM constructs.Limitations and difﬁculties in conducting the study
Phase 1 data collection through mailed surveys in the fall
2009 produced lower than expected results. Parent and school
ofﬁcial feedback implied that parents mistrusted calling into
a 1e800 number and answering even an anonymous survey over
the phone. So, the PI gave health promotion presentations in
local churches to increase visibility and community engagement.
In Phase 2 data collection methods, during spring 2010 of the
2009e2010 school year, data collection procedures were modi-
ﬁed to include face-to-face interaction, pen-and-pencil surveys,
and the choice to complete the survey on a secured research
laptop. Although the response rate was only 35% based on
student enrollment in the elementary and middle schools of the
target counties, this rate is likely an underestimate, inasmuch as
student enrollment ﬁgures do not directly equate to the exact
number of parents qualiﬁed to participate (Table 1). In addition,
other studies have also noted that rural areas have close-knit
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tion of health promotion activities [38,39]. However, mistrust of
healthcare providers and new healthcare interventions persist,
particularly among African Americans in rural areas [40].
Results
The ﬁnal dataset has data on 519 subjects. Sample sizes for
each variable are in Tables 3 and 4 along with all summary
statistics for the total sample and for each of the two groups
deﬁned by whether parents indicated that they would get their
child the HPV vaccine.
Demographic results yielded the following: parents or care-
givers who completed the surveys were mostly female (82.0%),
African American (77.3%), and self-identiﬁed as Baptist (76.4%).
Most had a family income of less than $30,000.00 annually
(61.0%) and were married (56.8%) (Table 3). Parents or caregivers
who completed the surveys were aged from 19 to 89 years:
41 years on average (SD ¼ 9.97). The children whose parents or
caregivers completed the PHPV survey were 11.4 years old on
average (SD ¼ 1.48). Households represented in the survey had
from no to seven girls in the family: 1.8 girls on average (SD ¼
1.02); from no to 6 boys: 1.0 boys on average (SD ¼ .78) (Table 4)
Of the 519 parents who completed the survey, 343 (66.1%)
indicated that they will not or had not vaccinated their child,
169 (32.6%) indicated that they will or had vaccinated their child,
and 7 (1.3%) did not respond to this question. Parents intending
to or having had their children vaccinated (yes) had more
boys (t¼2.16, df¼ 509, p¼ .03) (Table 4), were mostly mothers
(c2 ¼ 5.25, df ¼ 1, p ¼ .02), not African American (c2 ¼ 25.81,
df ¼ 1, p < .001), not Baptist (c2 ¼ 41.79, df ¼ 1, p < .001), and
better educated (c2 ¼ 13.71, df ¼ 1, p < .001) (Table 3).Table 3
Parental demographics (overall and by parents’ intention to vaccinate) study of human
Total Child vaccinated c2 t
(No) (Yes)
n % n % n %
Sex of parent
Male 92 18.0 71 20.7 21 12.4 c2 ¼
Female 420 82.0 272 79.3 148 87.6
Sex of child
Male 123 24.0 81 23.6 42 24.9 c2 ¼
Female 389 76.0 262 76.4 127 75.1
Race
African American 395 77.3 287 83.9 108 63.9 c2 ¼
Other 116 22.7 55 16.1 61 36.1
Religion
Baptist 389 76.4 289 85.0 100 59.2 c2 ¼
Other 120 23.6 51 15.0 69 40.8
Education level
Some high school or High school 297 58.2 218 63.9 79 46.7 c2 ¼
Some college 213 41.8 123 36.1 90 53.3
Income level c2 ¼
$15,000 or less 142 28.3 95 28.4 47 28.1
> $15,000 to $30,000 164 32.7 113 33.8 51 30.5
> $30,000 to $45,000 80 16.4 62 18.6 20 12.0
> $45,000 to $60,000 56 11.2 28 8.4 28 16.8
> $60,000 and greater 57 11.3 36 10.8 21 12.6
Marital status
Married or long term relationship 291 56.8 191 55.7 100 59.2 c2 ¼
Single, divorced or widowed 221 43.2 152 44.3 69 40.8
Know someone who has had an STD
Yes 198 44.0 130 45.3 68 41.7 c2 ¼
No 252 56.0 157 54.7 95 58.3Overall average agreement scores were as follows: perceived
vulnerability 40.4% (SD¼ 31.4), perceived severity 45.6 (SD¼ 29.1),
perceived beneﬁts 43.8 (SD ¼ 24.9), and perceived barriers 32.9
(SD¼ 23.7). The only signiﬁcant difference between the vaccination
and no-vaccination groups was in perceived barriers (t ¼ 2.304,
df¼ 510, p< .001) (Table 4). Table 5 shows that the vaccination rate
was highest in Burke county (46.1%), followed by Screven (32.2%)
and Lincoln (8.0%) counties. These rates appear to be associated
with the signiﬁcant differences between the counties’ cultural and
demographic makeup. Burke had the lowest percentage of African
Americans and Baptists, fewest girls per household, and most boys
per household. Burke County also had the highest percentage of
parents at the higher levels of education and income as well as
more parents who were married or in long-term relationships.
Each county had signiﬁcant differenceswith regard to sexof parent
surveyed, sex of child vaccinated, and parent’s age. Similarly, the
counties had signiﬁcant differences in scores on the subscales of
perceived vulnerability, perceived severity, and perceived beneﬁts
(Table 6). However, Lincoln’s vaccination ratewas so low (8.0%) that
this county’s data may not be sufﬁcient to adequately test trends in
vaccination for these variables.
The ﬁnal logistic regression model further investigated the
relationship between the demographic variables, the four HBM
constructs, and whether a parent had or intended to vaccinate
their child. Numbers of boys per household, and parent’s age,
race, religion, and level of education were all signiﬁcantly asso-
ciated with whether a parent had or intended to have a child
vaccinated (Tables 3 and 4). These ﬁve variables were considered
in the ﬁrst block of the regression model using forward likeli-
hood ratio variable selection to retain the best predictors in this
block. All four HBM constructs (or subscales) were considered in
the second block of the logistic regression model using forwardpapillomavirus (HPV) vaccine uptake in three rural Georgia counties, 2009e2011
est Point estimate Odds ratio
(ref category) [95% CI]
5.258, df ¼ 1, p ¼ .022 1.84 (female) [1.09, 3.11]
.095, df ¼ 1, p ¼ .758 .94 (female) [.61, 1.44]
25.816, df ¼ 1, p < .001 .34 (African American) [.22, .52]
41.797, df ¼ 1, p < .001 .26 (Baptist) [.17, .39]
13.719, df ¼ 1, p < .001 2.02 (some collegeþ) [1.39, 2.94]
.605, df ¼ 1, p ¼ .437 ($30K vs. >$30K) 1.16 (>$30K) [.80, 1.70]
.561, df ¼ 1, p ¼ .454 1.15 (married/LTR) [.79, 1.68]
.540, df ¼ 1, p ¼ .462 .86 (Yes) [.59, 1.28]
Table 4
Family demographics and four theoretical constructs, by parents’ intention to vaccinate: Study of human papillomavirus (HPV) vaccine uptake in three rural Georgia
counties, 2009e2011
Total Child vaccinated t test Mean difference [95% CI]
(No) (YES)
n Mean (SD) n Mean (SD) n Mean (SD)
Parent’s age 495 40.98 (9.97) 325 40.99 (10.22) 164 41.15 (9.61) t ¼ .169, df ¼ 487, p ¼.866 .16 [2.05, 1.72]
Child’s age 418 11.39 (1.48) 288 11.36 (1.49) 128 11.45 (1.47) t ¼ .511, df ¼ 414, p ¼ .609 .08 [.39, .23]
Number of female children 517 1.79 (1.02) 342 1.79 (0.98) 169 1.75 (1.09) t ¼ .489, df ¼ 509, p ¼ .625 .05 [.14, .24]
Number of male children 517 1.00 (.78) 342 .95 (.67) 169 1.11 (.96) t ¼ 2.165, df ¼ 509, p ¼ .031 .16 [.30, .02]
Four constructs
Perceived vulnerability 513 40.4 (31.4) 338 41.5 (31.9) 169 38.7 (30.6) t ¼ .938, df ¼ 505, p ¼ .349 [3.05, 8.61]
Perceived severity 516 45.6 (29.1) 341 44.4 (29.8) 169 48.5 (27.8) t ¼ 1.545, df ¼ 357.065, p ¼ .123 [9.41, 1.13]
Perceived beneﬁts 516 43.8 (24.9) 341 43.5 (25.8) 169 44.8 (23.2) t ¼ .577, df ¼ 368.506, p ¼ .564 [5.78, 3.15]
Perceived barriers 518 32.9 (23.7) 343 28.9 (23.1) 169 40.3 (22.8) t ¼ 2.304, df ¼ 510, <.001 [15.72, 7.22]
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demographic measures retained in Block 1.
Race and religion were the best two demographic predictors
within theﬁrst block (Table 7) and had large effect sizeswith odds
ratios greater than 2. After adjustment for race and religion
(which are still signiﬁcant with large odds ratios, Block 2 Table 7),
perceived beneﬁts and perceived barriers were both signiﬁcant
constructs (correlates) for vaccination. Adding these two
constructs to the model did improve the prediction of HPV
vaccination (Block 2 c2 ¼ 20.231, df ¼ 2, p < .001). It should
be noted that although perceived beneﬁts score was signiﬁcant
(p ¼ .025) the odds ratio (.988) was less than 1, which is not
intuitive, given that the average perceived beneﬁts score for
parents who had/will get their child vaccinated (44.8) was higher
than for parents who had not/will not get their child vaccinated
(43.5) (Table 4). However, these group differences were not
signiﬁcant (p ¼ .564, Table 4) when considering perceived bene-
ﬁts by itself. In the logistic regression model, the odds ratio for
perceive beneﬁts was signiﬁcant (p¼ .025) only conditional upon
(adjusting for) the effects of race, religion, and perceived barriers.
Although signiﬁcant, the effect size for perceivedbeneﬁts, anodds
ratio of .988, is minimalda 1% increase in perceived beneﬁts only
reduces the probability of a parent getting their child the vaccine
by (1 - .988)*100% ¼ 1.2 %, which is a very small effect size. It
should also be noted that when considered by itself without any
covariates or other predictors, the odds ratio for perceived bene-
ﬁts in the logistic regression model is 1.002 and is not signiﬁcant
(p ¼ .577), which agrees with the results presented in Table 4.
Discussion
Recent evidence suggests that HPV vaccine series initiation
among girls is still low nationally, 48%, and for boys may be asTable 5
Demographics and intention to vaccinate, by county: Study of human papillomavirus
Lincoln (n ¼ 113) Screven (n
Intend to vaccinate (yes) 8.0% 32.2%
Parent’s sex (male) 36.3% 7.4%
Child’s sex (male) 32.7% 9.7%
Race (African American) 100.0% 81.8%
Religion (Baptist) 100.0% 74.7%
Education ( high school grad) 86.7% 51.7%
Income (< $30K per year) 72.1% 60.8%
Marital status (married/LTRa) 45.1% 49.4%
a Long-term relationship.low as 2% nationally, and this rate is likely to be much lower in
rural areas, inasmuch as the series initiation rate among
females in rural Georgia is barely half the national average
[26,27]. Several factors combine to make protecting ethnic
minorities (especially those living in rural areas) from HPV-
related infection a public health priority: (1) the increasing
number of people from ethnic minority populations living in
the United States; (2) their high rates of cervical cancer; and
(3) the increasing prevalence of HPV-related cancers among
men [10].
To eliminate HPV-related cancers through HPV vaccination, it
is essential to recognize the factors involved in parents’ decision
whether to permit their children to get the HPV vaccination
[13,41]. Most research on parents’ acceptance of the HPV vaccine
was completed before the vaccine was licensed, and that
research focused predominantly on women living in urban areas
because the original focus was on preventing cervical cancer
[23,28e30]. Although the ﬁndings from these studies are valu-
able, they cannot be assumed to show how willing rural parents
with preadolescent and adolescent girls or boys would be to have
their children get the vaccine. Furthermore, women from
minority ethnic populations residing in rural areas have cervical
cancer at disproportionately higher rates than do white women
[42e44]. It is well documented that large populations of African
Americans and Hispanics in the United States experience
healthcare disparities and have limited access to basic primary
care, which limits their opportunities to get an HPV vaccination
[17,45e47]. Researchers of rural parents found that the parents
who experience healthcare disparities have children who also
experience healthcare disparities, especially in reproductive
health [48,49]. In communities where healthcare disparities
exist, study results imply that African-American parents may
have lower acceptability of the HPV vaccine than do other racial(HPV) vaccine uptake in three rural Georgia counties, 2009e2011
¼ 176) Burke (n ¼ 230) Test for differences
46.1% c2 ¼ 49.650, df ¼ 2, p < .001
16.6% c2 ¼ 39.724, df ¼ 2, p < .001
30.0% c2 ¼ 29.347, df ¼ 2, p < .001
62.7% c2 ¼ 62.990, df ¼ 2, p < .001
66.2% c2 ¼ 48.410. df ¼ 2, p < .001
48.9% c2 ¼ 48.902, df ¼ 2, p < .001
56.0% c2 ¼ 8.093, df ¼ 2, p < .017
68.6% c2 ¼ 23.082, df ¼ 2, p < .001
Table 6
Family demographics and four theoretical constructs, by county: Study of human papillomavirus (HPV) vaccine uptake in three rural Georgia counties, 2009e2011
Lincoln (n ¼ 113) Screven (n ¼ 176) Burke (n ¼ 230) Test for differences
Mean (SD) Mean (SD) Mean (SD)
Parent’s age 42.2 (11.5) 38.1 (7.7) 42.6 (10.3) F ¼ 11.242, df (2,494), p < .001
Child’s age 11.5 (1.5) 11.4 (1.6) 11.3 (1.4) F ¼ .587, df (2,417), p ¼ .556
Number of female children 2.0 (1.1) 2.0 (.9) 1.6 (1.0) F ¼ 8.880, df (2,516), p < .001
Number of male children .9 (.3) .9 (.8) 1.1 (.9) F ¼ 6.993, df (2,516), p ¼ .001
Four constructs
Perceived vulnerability 55.2 (25.1) 29.1 (29.8) 41.5 (32.3) F ¼ 26.149, df (2,512), p < .001
Perceived severity 58.1 (22.5) 38.6 (28.8) 44.7 (30.4) F ¼ 16.478, df (2,515), p < .001
Perceived beneﬁts 55.4 (15.7) 36.1 (25.7) 43.9 (25.9) F ¼ 22.340, df (2,515), p < .001
Perceived barriers 31.6 (20.8) 32.5 (25.4) 33.8 (23.8) F ¼ .359, df (2,517), p ¼ .698
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empirical data on the predictors of HPV vaccine acceptance or
refusal across racial groups in rural areas [50,51].
We found that in these isolated rural counties, parents had
low levels of HPV knowledge, as reﬂected by low scores on
perceived vulnerability to HPV infection and perceived severity
of HPV infection. Existing literature on perceived beneﬁts of the
HPV vaccine also implies that knowledge about the vaccine, and
speciﬁcally what it is used for, are essential to drive vaccine
uptake [52]. Corroborating other studies, we found that
encouragement from spouses or partners increases vaccine
uptake [53,54]. However, our results did not indicate that “what
others might think” was a barrier for those who chose not to
vaccinate. This is an important ﬁnding for providers practicing in
remote or isolated counties, where social norms play an impor-
tant role in when or where families obtain access to healthcare
[50].
After adjustment for race and religion, we found that
perceived beneﬁts and perceived barriers were signiﬁcant
predictors of vaccination for both girls and boys. This ﬁnding is
similar to the ﬁndings of other studies that identify perceived
beneﬁts as a strong predictor of HPV vaccination, and these
parents and young adults understood exactly what the HPV
vaccine was for and had access to healthcare services or a
healthcare provider [55,56].
Most pediatricians face the daily challenge of working with
families that are cautious or unconvinced about the safety of anyTable 7
Logistic regression model: Study of human papillomavirus (HPV) vaccine uptake in th
Measure Block 1
b SE b Odds ratio
Racea,b (0 ¼ African American; 1 ¼ other) .748 .236 2.113 (.002
Religiona,b (0 ¼ Baptist; 1 ¼ Other) 1.116 .230 3.054 (<.00
Perceived beneﬁts (higher % agree Items)
Perceived barriersb (higher % agree Items)
Constant 1.165 .125 .312 (< .0
Block c2, df (p value) 48.564, 2 (< .001)
Model c2, df (p value) 48.564, 2 (< .001)
2 log likelihood (2LL) 593.602
Nagelkerke R .128
Correctly classiﬁed 68.0%
Stepwise selection (forward likelihood ratio method) used to select variable to keep
Block 1: Demographic variables: number of male children, parent’s gender, race, relig
Block 2: Four theoretical constructs: perceived vulnerability, severity, beneﬁts, barrie
AA ¼ African American; CI ¼ conﬁdence interval; df ¼ degrees of freedom; p ¼ proba
a Religion and race were signiﬁcantly associated (85% of Baptists were African Ameri
b Perceived barrier scores were signiﬁcantly lower for African American (AA) than fo
t ¼ 2.749, df ¼ 515, p ¼ .005) and for Baptists (Baptists: mean ¼ 31.2 (SD ¼ 3.2); otvaccine. But with HPV vaccine uptake so low in rural areas,
healthcare providers have a unique opportunity to focus on
parents and caregivers who deem vaccines as safe and necessary
for the health of their children. Current literature supports the
signiﬁcance of parent/child discussions as a way to educate both
parents and children about HPV transmission and the poor
outcomes associated with HPV infection, a medium that can be
used by providers to effectively increase HPV vaccination during
interactions with parents and adolescents [57]. The ethnic, reli-
gious, educational, and cultural makeup of three rural counties in
this study also appeared to be highly associated with HPV
vaccination rates for both boys and girls, and awareness of the
role of these social, geographic, and cultural factors can help
promote the effectiveness of providers’ discussions with parents
and adolescents.
Zacharyczuk [58] urges primary care practitioners to use
a multifaceted approach to increasing vaccine uptake, and this
may be particularly important in rural isolated populations. Our
ﬁndings support this approach and indicate that perceived
beneﬁts and barriers are enmeshed with both race and religion
when rural parents make the decision to vaccinate their pread-
olescent or adolescent with the HPV vaccine. Thus, we recom-
mend a screening protocol for parental perceived beneﬁts of HPV
in conjunction with evaluating parents’ perceived vulnerability
or perceived severity in order to facilitate provider-parent
discussions and increase vaccine uptake. Before to seeing the
healthcare provider, support staff can screen patients to ascertainree rural Georgia counties, 2009e2011
Block 2 [95% CI]
(p value) b SE b Odds ratio (p value)
) .683 .239 1.980 (.004) [1.239, 3.165]
1) .979 .236 2.663 (<.001) [1.677, 4.229]
.012 .005 .988 (.025) [.978, .999]
.024 .005 1.024 (< .001) [1.013, 1.035]
01) 1.413 .233 .244 (< .001)
20.234, 2 (< .001)
68.798, 4 (< .001)






bility; SD ¼ standard deviation; t ¼ Student’s t test.
can; 52.1% of other religionswere African American; c2¼ 57.032, df¼ 1, p< .001).
r other races: (AA: mean¼ 31.4 (SD¼ 23.9); other races: mean¼ 38.2 (SD¼ 22.1);
her religions: mean ¼ 39.1 (SD ¼ 24.0); t ¼ 3.262, df ¼ 513, p ¼ .001).
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and their access to healthcare resources for vaccination. Armed
with that information (and personal knowledge of previous
patient-provider interactions), healthcare providers can begin
educating parents about HPV transmission, HPV-related cancers,
and HPV vaccination for both girls and boys.
A good time to begin a discussion about HPV with parents is
when othermandated vaccines such as hepatitis B are being given
to their children. To be successful, however, healthcare providers
must respect the parents’ cultural, religious, and moral views,
which theoretically predict their likelihood of accepting or
rejecting the HPV vaccine. By focusing on perceived barriers and
beneﬁts andonparents’ level of knowledgeaboutHPV, healthcare
providers can have frank conversations with parents in order to
facilitate the parents’ informed decision making about the HPV
vaccine. Building bonds of trust through open discussion can have
a substantial effect on the health of pediatric patients in rural
areas by reducing their risk for HPV-related cancer as adults.
Many children and adolescents raised in rural communities
are poor and may not have access to social, economic, or
educational opportunities to develop self-worth and indepen-
dence [59e63]. This lack can put them at risk for HPV infection
because they seek social status in other ways, including sexual
risk taking. Healthcare providers serving these children and
adolescents face constant challenges to ensuring that their
patients receive all the vaccinations they need. Discussions about
HPV vaccination with parents must be thorough and must
address parents’ fears that stem from inadequate information
and misinformation. Experts agree that the parents who refuse
vaccines (not only the HPV vaccine) cite safety and efﬁcacy
concerns as primary reasons to refuse any vaccine [51]. Ulti-
mately, the decision to vaccinate lies in the hands of the parent or
caregiver. However, when parents of children aged 9 to 13 years
who reside in underserved rural areas seek primary healthcare,
the healthcare provider should take the opportunity to discuss
the HPV vaccine with the parents, taking into consideration the
parents’ religious beliefs and level of education. Such discussions,
if conducted well and as often as needed, would increase HPV
vaccine uptake. Future health policy should include HPV vacci-
nation as one of the routine series of preadolescent and adoles-
cent vaccinations for both girls and boys.Acknowledgments
This work was funded by the Robert Wood Johnson Founda-
tion, ID # 67983.
Dr. Thomas gratefully acknowledges the cooperation and
support of the school ofﬁcials, community leaders, and parents of
Burke, Lincoln, and Screven Counties, Georgia.References
[1] Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine
2006;24(Suppl. 3):S3/11e25.
[2] Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is
a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:
12e9.
[3] Watson M, Saraiya M, Ahmed F, et al. Using population-based cancer
registry data to assess the burden of human papillomavirus-associated
cancers in the United States: Overview of methods. Cancer 2008;113-
(Suppl. 10):2841e54.
[4] Joseph DA, Miller JW, Wu X, et al. Understanding the burden of
human papillomavirus-associated anal cancers in the US. Cancer 2008;
113(Suppl. 10):2892e900.[5] Marklund L, Hammarstedt L. Impact of HPV in oropharyngeal cancer.
J Oncol 2011;2011:509036.
[6] Hernandez BY, Barnholtz-Sloan J, German RR, et al. Burden of invasive
squamous cell carcinoma of the penis in the United States, 1998-2003.
Cancer 2008;113(Suppl. 10):2883e91.
[7] Wu X, Matanoski G, Chen VW, et al. Descriptive epidemiology of vaginal
cancer incidence and survival by race, ethnicity, and age in the United
States. Cancer 2008;113(Suppl. 10):2873e82.
[8] Saraiya M, Watson M, Wu X, et al. Incidence of in situ and invasive vulvar
cancer in the US, 1998-2003. Cancer 2008;113(Suppl. 10):2865e72.
[9] Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Years of potential
life lost and productivity costs because of cancer mortality and for speciﬁc
cancer sites where human papillomavirus may be a risk factor for
carcinogenesis-United States, 2003. Cancer 2008;113(Suppl. 10):2936e45.
[10] Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-speciﬁc prev-
alence of human papillomavirus infection in males: A global review.
J Adolesc Health 2011;48:540e52.
[11] Chaturvedi AK. Beyond cervical cancer: Burden of other HPV-related cancers
among men and women. J Adolesc Health 2010;46(Suppl. 4):S20e6.
[12] FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gar-
dasil) for use in males and guidance from the Advisory Committee on
Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:
630e2.
[13] Vaccination coverage among adolescents aged 13-17 years - United States,
2007. MMWR Morb Mortal Wkly Rep Oct 10 2008;57(40):1100e3.
[14] Scientiﬁc Report: U.S. Department of Health and Human Services, Centers
for Disease Control and Prevention, National Cancer Institute 2006 United
States Cancer Statistics. Washington, DC: Incidence and Mortality; 2003.
[15] Cancer Facts and Figures, 2008. Atlanta: American Cancer Society; 2008.
[16] Rodgers KB. Parenting processes related to sexual risk-taking behaviors of
adolescent males and females. J Marriage Fam 1999;61:99e109.
[17] Zimet GD. Understanding and overcoming barriers to human papilloma-
virus vaccine acceptance. Curr Opin Obstet Gynecol 2006;18(Suppl. 1):
s23e8.
[18] Slomovitz BM, Sun CC, Frumovitz M, et al. Are women ready for the HPV
vaccine? Gynecol Oncol 2006;103:151e4.
[19] Schuler CL, Reiter PL, Smith JS, Brewer NT. Human papillomavirus vaccine
and behavioural disinhibition. Sex Transm Infect 2011;87:349e53.
[20] Marlow LA, Forster AS, Wardle J, Waller J. Mothers’ and adolescents’ beliefs
about risk compensation following HPV vaccination. J Adolesc Health 2009;
44:446e51.
[21] Brewer NT, Cuite CL, Herrington JE, Weinstein ND. Risk compensation and
vaccination: Can getting vaccinated cause people to engage in risky
behaviors? Ann Behav Med 2007;34:95e9.
[22] Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and
sexual behavior among adolescent and young women. Am J Prevent Med
2012;42:44e52.
[23] Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine
acceptability among parents of 10- to 15-year-old adolescents. J Low Genit
Tract Dis 2004;8:188e94.
[24] Geronimus AT, Colen CG, Shochet T, et al. Urban-rural differences in excess
mortality among high-poverty populations: Evidence from the Harlem
Household Survey and the Pitt County, North Carolina Study of African
American Health. J Health Care Poor Underserved 2006;17:532e58.
[25] O’Sullivan LF, Meyer-Balhburg HF, Watkins BX. Social cognitions associated
with pubertal development in a sample of urban, low-income, African-
American and Latina girls and mothers. J Adolesc Health 2000;27:227e35.
[26] Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent
males. Vaccine 2011;29:5595e602.
[27] CDC. National and state vaccination coverage among adolescents aged 13
through 17 yearseUnited States, 2010. MMWR Morb Mortal Wkly Rep
2011;60:1117e23.
[28] Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-
informed, systematic review. Prev Med 2007;45:107e14.
[29] Liddon N, Pulley L, Cockerham WC, et al. Parents’/guardians’ willingness to
vaccinate their children against genital herpes. J Adolesc Health 2005;37:
187e93.
[30] Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: Demo-
graphics, sexual history and values, parenting style, and vaccine attitudes.
J Adolesc Health 2008;43:239e45.
[31] Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health
education: Theory, research, and practice. 4th edition. San Francisco: Jos-
sey-Bass; 2008.
[32] Bergren MD. Privacy questions from practicing school nurses. J Sch Nurs
2004;20:296e301.
[33] Dunlop AL, Graham T, Leroy Z, et al. The impact of HIPAA authorization on
willingness to participate in clinical research. Ann Epidemiol 2007;17:
899e905.
[34] Midanik LT, Greenﬁeld TK. Interactive voice response versus computer-
assisted telephone interviewing (CATI) surveys and sensitive questions:
The 2005 National Alcohol Survey. J Stud Alcohol Drugs 2008;69:580e8.
T.L. Thomas et al. / Journal of Adolescent Health 52 (2013) S60eS68S68[35] Thomas T, Strickland O, DiClemente R, Higgins M, Williams B, Hickey K.
Parental Human Papillomavirus Vaccine Survey (PHPVS): Nurse led
instrument development and psychometric testing for use in research and
primary care screening. J Nurs Meas. In press.
[36] Bollen KA, Lennox R. Conventional wisdom on measurement: A structural
equation perspective. Psychol Bull 1991;110:305e14.
[37] Bollen KA. Multiple indicators: Internal consistency or no necessary rela-
tionship? Qual Quant 1984:377e85.
[38] Kennedy BR, Mathis CC, Woods AK. African Americans and their distrust of
the health care system: Healthcare for diverse populations. J Cult Divers
2007;14:56e60.
[39] Crosby R, Yarber W, DiClemente R, et al. HIV-associated histories,
perceptions, and practices among low-income African American women:
Does rural residence matter? Am Public Health Assoc 2002;92:655e9.
[40] Moseley KL, Freed GL, Bullard CM, Goold SD. Measuring African-American
parents’ cultural mistrust while in a healthcare setting: A pilot study. J Natl
Med Assoc 2007;99:15e21.
[41] Harper DM, Franco EL, Wheeler CM, et al. Sustained efﬁcacy up to 4.5 years
of a bivalent L1 virus-like particle vaccine against human papillomavirus
types 16 and 18: Follow-up from a randomised control trial. Lancet 2006;
367:1247e55.
[42] Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of
cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino pop-
ulations. Cancer 2006;107:1711e42.
[43] Detailed guide: Cervical cancer. What are the Key Statistics about cervical
cancer? 2005; http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_
What_are_the_key_statistics_for_cervical_cancer_8.asp. Accessed July 26,
2011.
[44] Georgia Cancer Data Report, 2005. Atlanta: Georgia Center for Cancer
Statistics; 2007.
[45] Raffaelli M, Ontai LL. ‘She’s 16 years old and there’s boys calling over to the
house’: An exploratory study of sexual socialization in Latino families. Cult
Health Sex 2001;3:295e310.
[46] Flores G. Technical reporteracial and ethnic disparities in the health and
health care of children. Pediatrics 2010;125:e979e1020.
[47] Mahmoudi E, Jensen GA. Diverging racial and ethnic disparities in access to
physician care: Comparing 2000 and 2007. Med Care 2012;50:327e34.
[48] Charo RA. Politics, parents, and prophylaxisemandating HPV vaccination in
the United States. N Engl J Med 2007;356:1905e8.[49] Eisenberg ME, Bearinger LH, Sieving RE, et al. Parents’ beliefs about
condoms and oral contraceptives: Are they medically accurate? Perspect
Sex Reprod Health 2004;36:50e7.
[50] Aral SO, Adimora AA, Fenton KA. Understanding and responding to
disparities in HIV and other sexually transmitted infections in African
Americans. Lancet 2008;372:337e40.
[51] Loftin WA, Barnett SK, Bunn PS, Sullivan P. Recruitment and retention of
rural African Americans in diabetes research: Lessons learned. Diabetes
Educ 2005;31:251e9.
[52] Ford C, English A, Davenport A, Stinnett A. Increasing adolescent vaccina-
tion: Barriers and strategies in the context of policy, legal, and ﬁnancial
issues. J Adolesc Health 2009;44:568e74.
[53] Bair RM, Mays RM, Sturm LA, Zimet GD. Acceptability of the human
papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol
2008;21:329e34.
[54] Dunne EF, Datta SD, Markowitz EL. A review of prophylactic human
papillomavirus vaccines: Recommendations and monitoring in the US.
Cancer 2008;113(Suppl. 10):2995e3003.
[55] Luque JS, Castaneda H, Martinez Tyson D, et al. Formative research on HPV
vaccine acceptability among Latina farmworkers. Health Promot Pract
2012;13:617e25.
[56] Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV
vaccination. Vaccine 2007;25:1945e52.
[57] McRee AL, Reiter PL, Gottlieb SL, Brewer NT. Mother-daughter communi-
cation about HPV vaccine. J Adolesc Health 2011;48:314e7.
[58] Zacharyczuk C. Multifaceted approach advocated for vaccine-hesitant
parents. Infect Dis Child 2011;24:1e11.
[59] Adler NE, Rehkopf DH. U.S. disparities in health: Descriptions, causes, and
mechanisms. Annu Rev Public Health 2008;29:235e52.
[60] Comber AJ, Brunsdon C, Radburn R. A spatial analysis of variations in health
access: Linking geography, socio-economic status and access perceptions.
Int J Health Geogr 2011;10:44.
[61] Conroy K, Sandel M, Zuckerman B. Poverty grown up: How childhood socio-
economic status impacts adult health. J Dev Behav Pediatr 2010;31:154e60.
[62] Fiscella K, Kitzman H. Disparities in academic achievement and health: The
intersectionofchildeducationandhealthpolicy.Pediatrics2009;123:1073e80.
[63] Krieger JL, Katz ML, Kam JA, Roberto A. Appalachian and non-Appalachian
pediatricians’ encouragement of the human papillomavirus vaccine:
Implications for health disparities.Women’s Health Issues 2012;22:e19e26.
